Company CEO Albert Bourla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech but said he has not yet taken the new bivalent booster.
https://www.pharmalive.com/wp-content/uploads/2022/09/AlbertBourla-Pfizer-2022.jpeg600898Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-24 18:00:502022-09-26 10:13:31Pfizer CEO tests positive for COVID for a second time
